Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii

Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness

(2013) Rafael López-Rojas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?

(2013) A. Beceiro et al.   CLINICAL MICROBIOLOGY REVIEWS

Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections

(2013) Emil Lesho et al.   JOURNAL OF INFECTIOUS DISEASES

Real-Time Sequencing To Decipher the Molecular Mechanism of Resistance of a Clinical Pan-Drug-Resistant Acinetobacter baumannii Isolate from Marseille, France

(2012) Jean-Marc Rolain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression of OXA-Type and SFO-1 β-Lactamases Induces Changes in Peptidoglycan Composition and Affects Bacterial Fitness

(2012) Ana Fernández et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis

(2012) L. Lin et al.   mBio

Genome-Wide Identification of Pseudomonas aeruginosa Virulence-Related Genes Using a Caenorhabditis elegans Infection Model

(2012) Rhonda L. Feinbaum et al.   PLoS Pathogens

OmpK26, a Novel Porin Associated with Carbapenem Resistance in Klebsiella pneumoniae

(2011) Laura García-Sureda et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Insertion Sequence ISAba11Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii

(2011) Jennifer H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A

(2011) Luis A. Arroyo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine

(2011) Rebekah Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System

(2011) Alejandro Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Correlation between overexpression and amino acid substitution of the PmrAB locus and colistin resistance in Acinetobacter baumannii

(2011) Young Kyoung Park et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Effect of colistin exposure and growth phase on the surface properties of live Acinetobacter baumannii cells examined by atomic force microscopy

(2011) Rachel L. Soon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Acinetobacter baumannii Resistant to Colistin Alters Its Antibiotic Resistance Profile: A Case Report From Spain

(2011) Rafael López-Rojas et al.   JOURNAL OF INFECTIOUS DISEASES

Acinetobacter baumannii Resistant to Colistin With Impaired Virulence: A Case Report From France

(2011) J.-M. Rolain et al.   JOURNAL OF INFECTIOUS DISEASES

Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii

(2011) Rafael López-Rojas et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

(2011) Efthimia Tasina et al.   LANCET INFECTIOUS DISEASES

In Vitro Antimicrobial Activity and Mutant Prevention Concentration of Colistin against Acinetobacter baumannii

(2010) Y. Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

(2010) J. H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-ResistantAcinetobacter baumannii

(2010) Michael J. McConnell et al.   INFECTION AND IMMUNITY

A Single Clone of Acinetobacter baumannii, ST22, Is Responsible for High Antimicrobial Resistance Rates of Acinetobacter Spp. Isolates That Cause Bacteremia and Urinary Tract Infections in Korea

(2010) Young Kyoung Park et al.   Microbial Drug Resistance

The cation-uptake regulators AdcR and Fur are necessary for full virulence of Streptococcus suis

(2010) Jesús Aranda et al.   VETERINARY MICROBIOLOGY

In Vitro Activity and In Vivo Efficacy of Clavulanic Acid against Acinetobacter baumannii

(2009) A. Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System

(2009) M. D. Adams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea

(2009) Young Kyoung Park et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective

(2009) María Fernández-Reyes et al.   PROTEOMICS

The ability to enter into an avirulent viable but non-culturable (VBNC) form is widespread amongListeria monocytogenesisolates from salmon, patients and environment

(2009) Toril Lindbäck et al.   VETERINARY RESEARCH

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS